𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients

✍ Scribed by Rousselot, P; Larghero, J; Arnulf, B; Poupon, J; Royer, B; Tibi, A; Madelaine-Chambrin, I; Cimerman, P; Chevret, S; Hermine, O

Book ID
110055948
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
121 KB
Volume
18
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II clinical trial of arsenic triox
Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma
✍ C.C. Hofmeister; B. Jansak; N. Denlinger; E.H. Kraut; D.M. Benson; S.S. Farag πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 90 KB

In patients with multiple myeloma, there is preclinical justification to combine arsenic trioxide (ATO and As 2 O 3 ) with DVd (Doxil TM , vincristine, and dexamethasone) for newly diagnosed patients. Eleven patients on this phase II trial received 0.15 mg/kg of ATO for five consecutive days followe